By Alexander Bueso
Date: Monday 14 Sep 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
No recent information was found.
| Currency | Euro |
| Share Price | 308.48 |
| Change Today | 2.88 |
| % Change | 0.94 % |
| 52 Week High | 330.00 |
| 52 Week Low | 203.60 |
| Volume | 27,021 |
| Shares Issued | 8.35m |
| Market Cap | 2,575.42m |
| Beta | 0.51 |
| Time | Volume / Share Price |
| 12:20 | 9 @ 308.40 |
| 12:20 | 4 @ 308.40 |
| 12:20 | 2 @ 308.40 |
| 12:20 | 7 @ 308.40 |
| 12:18 | 36 @ 308.00 |
You are here: research